Westside Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.9K | Sell |
1,286
-50
| -4% | -$2.71K | 0.01% | 564 |
|
|
2026
Q1 | $83.9K | Hold |
1,336
| – | – | 0.01% | 441 |
|
|
2025
Q4 | $127K | Buy |
1,336
+9
| +0.7% | +$882 | 0.02% | 353 |
|
|
2025
Q3 | $128K | Buy |
1,327
+351
| +36% | +$36.4K | 0.02% | 356 |
|
|
2025
Q2 | $104K | Buy |
976
+351
| +56% | +$35.5K | 0.02% | 342 |
|
|
2025
Q1 | $63.1K | Hold |
625
| – | – | 0.01% | 369 |
|
|
2024
Q4 | $55.8K | Hold |
625
| – | – | 0.01% | 389 |
|
|
2024
Q3 | $51.9K | Hold |
625
| – | – | 0.01% | 398 |
|
|
2024
Q2 | $48.1K | Buy |
625
+50
| +9% | +$3.66K | 0.01% | 396 |
|
|
2024
Q1 | $39.4K | Hold |
575
| – | – | 0.01% | 413 |
|
|
2023
Q4 | $33.2K | Hold |
575
| – | – | 0.01% | 419 |
|
|
2023
Q3 | $30.4K | Hold |
575
| – | – | 0.01% | 425 |
|
|
2023
Q2 | $31.1K | Hold |
575
| – | – | 0.01% | 427 |
|
|
2023
Q1 | $28.8K | Sell |
575
-50
| -8% | -$2.36K | 0.01% | 443 |
|
|
2022
Q4 | $28 | Hold |
625
| – | – | ﹤0.01% | 483 |
|
|
2022
Q3 | $24 | Hold |
625
| – | – | ﹤0.01% | 494 |
|
|
2022
Q2 | $23 | Hold |
625
| – | – | ﹤0.01% | 492 |
|
|
2022
Q1 | $27 | Hold |
625
| – | – | ﹤0.01% | 480 |
|
|
2021
Q4 | $26 | Hold |
625
| – | – | ﹤0.01% | 464 |
|
|
2021
Q3 | $27 | Hold |
625
| – | – | ﹤0.01% | 451 |
|
|
2021
Q2 | $26 | Hold |
625
| – | – | ﹤0.01% | 448 |
|
|
2021
Q1 | $24 | Hold |
625
| – | – | ﹤0.01% | 440 |
|
|
2020
Q4 | $22 | Hold |
625
| – | – | ﹤0.01% | 417 |
|
|
2020
Q3 | $23 | Hold |
625
| – | – | ﹤0.01% | 405 |
|
|
2020
Q2 | $21 | Hold |
625
| – | – | ﹤0.01% | 394 |
|
|
2020
Q1 | $20 | Buy |
+625
| New | +$24.4K | ﹤0.01% | 392 |
|
|
2019
Q2 | $31 | Buy |
+725
| New | +$27.9K | ﹤0.01% | 361 |
|
|
2018
Q4 | $25.6K | Hold |
725
| – | – | 0.01% | 358 |
|
|
2018
Q3 | $28.3K | Hold |
725
| – | – | 0.01% | 307 |
|
|
2018
Q2 | $23.8K | Hold |
725
| – | – | 0.01% | 382 |
|
|
2018
Q1 | $19.5K | Hold |
725
| – | – | 0.01% | 394 |
|
|
2017
Q4 | $18.7K | Hold |
725
| – | – | 0.01% | 420 |
|
|
2017
Q3 | $21.3K | Hold |
725
| – | – | 0.01% | 379 |
|
|
2017
Q2 | $20K | Buy |
725
+225
| +45% | +$5.97K | 0.01% | 386 |
|
|
2017
Q1 | $12.2K | Hold |
500
| – | – | 0.01% | 449 |
|
|
2016
Q4 | $11.7K | Buy |
+500
| New | +$10.9K | 0.01% | 367 |
|
Other funds holding BSX
Westside Investment Management's BSX Position: Q2 2026 in Review
Westside Investment Management reduced its Boston Scientific (BSX) stake by 3.7% in Q2 2026, selling an estimated $2.71K and leaving 1,286 shares worth $54.9K. The position accounts for 0.01% of the portfolio, ranked #564.
Westside Investment Management first reported a position in BSX in Q4 2016 and has held it in 36 quarters since. The position peaked at $128K in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Westside Investment Management held 1,286 shares of Boston Scientific worth $54.9K as of Q2 2026.
- Westside Investment Management sold 50 Boston Scientific shares in Q2 2026, an estimated $2.71K.
- Boston Scientific made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #564 holding.
- Westside Investment Management first reported a position in Boston Scientific in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Boston Scientific position peaked at $128K in Q3 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.